Financial statements
Balance Sheet
As at 31 December 2022
| Note | 2022 USD’000 |
2021 USD’000 |
|
| Subsidiaries | 8 |
1,491,148 |
1,153,459 |
| Joint venture | 9 | – |
10,213 |
|
Loans receivable from subsidiary |
7 |
4,900 |
4,900 |
|
Total non-current assets |
1,496,048 |
1,168,572 |
|
|
Other receivables |
6 |
165,588 |
111,746 |
|
Loans receivable from subsidiary |
7 |
8,427 |
8,266 |
|
Cash and cash equivalents |
10 |
1,940 |
*- |
|
Total current assets |
175,955 |
120,012 |
|
|
Total assets |
1,672,003 |
1,288,584 |
|
|
Share capital |
11 |
5,035 |
3,703 |
|
Share premium |
11 |
1,023,996 |
704,834 |
|
Contributed surplus |
537,112 |
537,112 |
|
|
Merger reserve |
(76,657) |
(76,657) |
|
|
Share-based payment reserve |
5,873 |
4,837 |
|
|
Capital reserve |
(710) |
– |
|
|
Treasury shares |
(12,675) |
(12,832) |
|
|
Retained earnings |
188,226 |
47,672 |
|
|
Total shareholders’ equity |
1,670,200 |
1,208,669 |
|
|
Other payables |
13 |
1,803 |
79,915 |
|
Total liabilities |
1,803 |
79,915 |
|
|
Total equity and liabilities |
1,672,003 |
1,288,584 |
|
* Amount less than USD 1,000.